GKOS

Glaukos Corporation NYSE

Healthcare ·Medical - Devices ·US · glaukos.com

$133.42

Mkt Cap $7.8B

52w Low $73.16 81.9% of range 52w High $146.75

50d MA $114.89 200d MA $102.18

P/E (TTM) -42.8x

EV/EBITDA -43.3x

P/B 12.2x

Debt/Equity 0.2x

ROE -28.6%

P/FCF -119.6x

RSI (14) —

ATR (14) —

Beta 0.78

50d MA $114.89

200d MA $102.18

Avg Volume 713.5K

About

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's produc…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	AMC	-0.30	-0.18	+40.0%	116.96	+21.0%	+22.8%	+19.9%	+16.2%	+15.5%	—	—
Feb 17, 2026	AMC	-0.22	-0.28	-27.3%	106.64	-2.9%	+13.5%	+9.8%	+12.8%	+12.9%	+11.7%	—
Oct 29, 2025	AMC	-0.27	-0.16	+40.7%	77.09	+23.3%	+13.9%	+14.2%	+13.4%	+11.5%	+9.4%	—
Jul 30, 2025	AMC	-0.26	-0.24	+7.7%	94.05	-0.6%	-8.5%	-8.4%	-7.0%	-6.4%	-5.9%	—
Apr 30, 2025	AMC	-0.33	-0.22	+33.3%	94.25	-10.4%	-11.4%	-7.0%	-7.8%	-7.5%	-6.4%	—
Feb 20, 2025	AMC	-0.38	-0.40	-5.3%	157.36	-10.2%	-20.0%	-21.0%	-23.4%	-23.4%	-24.8%	—
Nov 4, 2024	AMC	-0.52	-0.28	+46.2%	131.38	-4.9%	-2.7%	+7.0%	+6.1%	+7.9%	+8.9%	—
Jul 31, 2024	AMC	-0.52	-0.52	+0.0%	117.17	-5.2%	+0.4%	-1.0%	-3.0%	-0.4%	-1.1%	—
May 1, 2024	AMC	-0.58	-0.70	-20.7%	98.91	-2.0%	+6.2%	+7.7%	+6.2%	+9.2%	+8.1%	—
Feb 21, 2024	AMC	-0.56	-0.63	-12.5%	92.79	+3.0%	-1.4%	-3.5%	-1.3%	-2.5%	-3.0%	—
Nov 1, 2023	AMC	-0.56	-0.50	+10.7%	69.43	-4.8%	-7.6%	-7.5%	-7.8%	-10.3%	-7.6%	—
Aug 2, 2023	AMC	-0.57	-0.55	+3.5%	74.72	-2.1%	-0.4%	-0.4%	+0.6%	+0.1%	-3.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 30	Citigroup	Maintains	Buy → Buy	—	$116.96	$141.50	+21.0%	+22.8%	+19.9%	—	—	—
Apr 30	Needham	Maintains	Buy → Buy	—	$116.96	$141.50	+21.0%	+22.8%	+19.9%	—	—	—
Apr 30	Wells Fargo	Maintains	Overweight → Overweight	—	$116.96	$141.50	+21.0%	+22.8%	+19.9%	—	—	—
Apr 30	JP Morgan	Maintains	Overweight → Overweight	—	$116.96	$141.50	+21.0%	+22.8%	+19.9%	—	—	—
Apr 30	BTIG	Maintains	Buy → Buy	—	$116.96	$141.50	+21.0%	+22.8%	+19.9%	—	—	—
Feb 18	Needham	Maintains	Buy → Buy	—	$106.64	$103.55	-2.9%	+13.5%	+9.8%	+12.8%	+12.9%	+11.7%
Feb 18	BTIG	Maintains	Buy → Buy	—	$106.64	$103.55	-2.9%	+13.5%	+9.8%	+12.8%	+12.9%	+11.7%
Feb 18	Wells Fargo	Maintains	Overweight → Overweight	—	$106.64	$103.55	-2.9%	+13.5%	+9.8%	+12.8%	+12.9%	+11.7%
Jan 28	BTIG	Maintains	Buy → Buy	—	$118.70	$122.10	+2.9%	+4.4%	+0.3%	+0.6%	-1.0%	-0.5%
Jan 22	Stifel	Maintains	Buy → Buy	—	$124.16	$126.98	+2.3%	+1.4%	-3.4%	+0.1%	-4.4%	-0.2%
Jan 14	Needham	Maintains	Buy → Buy	—	$110.23	$94.81	-14.0%	-5.3%	+3.9%	+9.1%	+12.0%	+12.6%
Jan 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$112.91	$114.47	+1.4%	-1.9%	-0.4%	-0.6%	+0.7%	+1.1%
Jan 2	BTIG	Maintains	Buy → Buy	—	$112.91	$114.47	+1.4%	-1.9%	-0.4%	-0.6%	+0.7%	+1.1%
Dec 23	UBS	Maintains	Buy → Buy	—	$117.09	$116.83	-0.2%	-0.8%	-0.4%	-0.8%	-1.3%	-2.4%
Dec 18	Truist	Maintains	Buy → Buy	—	$112.42	$114.32	+1.7%	+0.7%	+3.4%	+4.2%	+3.3%	+3.8%
Dec 11	Citigroup	Maintains	Buy → Buy	—	$108.72	$109.20	+0.4%	+0.5%	+0.1%	+2.8%	+4.6%	+3.4%
Dec 9	Needham	Maintains	Buy → Buy	—	$108.46	$108.96	+0.5%	-1.5%	+0.2%	+0.7%	+0.4%	+3.0%
Oct 30	Wells Fargo	Maintains	Overweight → Overweight	—	$77.09	$95.07	+23.3%	+13.9%	+14.2%	+13.4%	+11.5%	+9.4%
Oct 30	Citigroup	Maintains	Buy → Buy	—	$77.09	$95.07	+23.3%	+13.9%	+14.2%	+13.4%	+11.5%	+9.4%
Oct 30	BTIG	Maintains	Buy → Buy	—	$77.09	$95.07	+23.3%	+13.9%	+14.2%	+13.4%	+11.5%	+9.4%
Oct 30	Needham	Maintains	Buy → Buy	—	$77.09	$95.07	+23.3%	+13.9%	+14.2%	+13.4%	+11.5%	+9.4%
Oct 30	JP Morgan	Maintains	Overweight → Overweight	—	$77.09	$95.07	+23.3%	+13.9%	+14.2%	+13.4%	+11.5%	+9.4%
Oct 27	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$74.67	$79.50	+6.5%	+1.4%	+4.2%	+3.2%	+17.6%	+17.9%
Oct 20	BTIG	Maintains	Buy → Buy	—	$87.17	$88.80	+1.9%	-8.8%	-13.0%	-12.1%	-13.7%	-14.3%
Oct 13	BTIG	Maintains	Buy → Buy	—	$82.56	$83.58	+1.2%	+0.6%	+3.3%	+3.7%	+3.4%	+5.6%
Oct 7	Citigroup	Maintains	Buy → Buy	—	$86.62	$86.66	+0.0%	-2.9%	+1.1%	+0.5%	-4.7%	-4.1%
Sep 22	Truist	Maintains	Buy → Buy	—	$83.47	$81.86	-1.9%	+1.4%	+1.5%	-0.8%	-2.4%	-4.3%
Sep 10	BTIG	Maintains	Buy → Buy	—	$90.91	$90.37	-0.6%	-3.7%	-3.8%	-9.0%	-11.3%	-9.4%
Jul 31	UBS	Maintains	Buy → Buy	—	$94.05	$93.50	-0.6%	-8.5%	-8.4%	-7.0%	-6.4%	-5.9%
Jul 31	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$94.05	$93.50	-0.6%	-8.5%	-8.4%	-7.0%	-6.4%	-5.9%
May 6	Morgan Stanley	Maintains	Underweight → Underweight	—	$86.86	$85.13	-2.0%	+0.4%	+1.6%	+4.2%	+3.6%	+9.0%
May 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$83.54	$84.59	+1.3%	+4.9%	+4.0%	+4.4%	+5.6%	+8.4%
May 1	Stifel	Maintains	Buy → Buy	—	$94.25	$84.42	-10.4%	-11.4%	-7.0%	-7.8%	-7.5%	-6.4%
May 1	Truist	Maintains	Buy → Buy	—	$94.25	$84.42	-10.4%	-11.4%	-7.0%	-7.8%	-7.5%	-6.4%
May 1	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$94.25	$84.42	-10.4%	-11.4%	-7.0%	-7.8%	-7.5%	-6.4%
May 1	Needham	Maintains	Buy → Buy	—	$94.25	$84.42	-10.4%	-11.4%	-7.0%	-7.8%	-7.5%	-6.4%
Apr 16	Mizuho	Maintains	Outperform → Outperform	—	$94.52	$92.85	-1.8%	-6.1%	-4.5%	-6.6%	-5.1%	-2.0%
Apr 15	Piper Sandler	Maintains	Overweight → Overweight	—	$92.91	$93.03	+0.1%	+1.7%	-4.4%	-2.9%	-5.0%	-3.4%
Apr 11	Truist	Maintains	Buy → Buy	—	$89.66	$89.66	+0.0%	+0.5%	+3.6%	+5.4%	-1.0%	+0.7%
Feb 21	Wells Fargo	Maintains	Overweight → Overweight	—	$157.36	$141.35	-10.2%	-20.0%	-21.0%	-23.4%	-23.4%	-24.8%
Feb 21	Needham	Maintains	Buy → Buy	—	$157.36	$141.35	-10.2%	-20.0%	-21.0%	-23.4%	-23.4%	-24.8%
Feb 19	Mizuho	Upgrade	Neutral → Outperform	—	$152.96	$156.70	+2.4%	+5.0%	+2.9%	-17.7%	-18.8%	-21.2%
Jan 27	Piper Sandler	Maintains	Overweight → Overweight	—	$160.22	$159.21	-0.6%	-2.0%	-0.3%	-0.8%	-1.5%	-2.4%
Dec 31	Stifel	Maintains	Buy → Buy	—	$149.51	$152.45	+2.0%	+0.3%	+0.1%	+1.3%	+3.8%	+4.7%
Dec 18	Truist	Maintains	Buy → Buy	—	$146.35	$146.44	+0.1%	-0.8%	-1.8%	+3.1%	+1.4%	+3.3%
Dec 11	Citigroup	Upgrade	Neutral → Buy	—	$136.38	$140.91	+3.3%	+4.8%	+2.9%	+1.9%	+5.7%	+7.3%
Dec 11	Wells Fargo	Maintains	Overweight → Overweight	—	$136.38	$140.91	+3.3%	+4.8%	+2.9%	+1.9%	+5.7%	+7.3%
Dec 2	Stifel	Maintains	Buy → Buy	—	$143.65	$140.00	-2.5%	-3.2%	-5.3%	-3.7%	-5.5%	-2.3%
Dec 2	Morgan Stanley	Downgrade	Equal Weight → Underweight	—	$143.65	$140.00	-2.5%	-3.2%	-5.3%	-3.7%	-5.5%	-2.3%
Nov 26	BTIG	Maintains	Buy → Buy	—	$142.94	$144.00	+0.7%	-1.5%	-0.2%	+0.5%	-2.7%	-4.9%

Recent Filings

8-K · 7.01 ! Medium

Glaukos Corporation -- 8-K 7.01: Regulation FD Disclosure

Glaukos Corporation released investor presentation materials on its website, signaling management's intent to communicate strategic updates and financial performance to shareholders and stakeholders regularly.

May 4

8-K · 7.01 ! Medium

Glaukos Corporation -- 8-K 7.01: Regulation FD Disclosure

Glaukos Corporation disclosed first-quarter 2026 supplemental financial information via 8-K filing, providing investors updated business metrics and performance data for the period ending March 31, 2026.

Apr 29

8-K · 7.01 ! Medium

Glaukos Corporation -- 8-K 7.01: Regulation FD Disclosure

Glaukos Corporation disclosed investor presentation materials highlighting its business strategy and financial outlook to shareholders and stakeholders via regulatory filing.

Mar 2

8-K · 7.01 ! Medium

Glaukos Corporation -- 8-K 7.01: Regulation FD Disclosure

Glaukos Corporation released supplemental Q4 2025 financial and business information through an 8-K filing, providing investors with detailed quarterly performance data on its investor relations website.

Feb 17

Data updated apr 25, 2026 11:31am · Source: massive.com